New Lab Test May Detect Cancer Up to Three Years Before Diagnosis

A major breakthrough in cancer detection could change the way doctors screen for the disease—and save lives in the process.

Researchers at Johns Hopkins University have developed a multicancer early detection laboratory test that can identify cancer-related genetic material in the blood up to three years before a traditional diagnosis. The findings suggest a future where doctors may catch cancer long before symptoms appear—when treatment is more likely to succeed.

The test works by scanning blood samples for fragments of tumor DNA, which are often present in the bloodstream even in the earliest stages of cancer. In the study, the lab was able to detect these cancer signals years ahead of a conventional diagnosis, giving patients a crucial head start.

“Cancers are usually much less advanced with very early detection and are more easily treated and cured,” said lead study author Yuxuan Wang, emphasizing the potential impact of catching cancer before it spreads or becomes harder to manage.

While more research is needed, experts believe this kind of “liquid biopsy” technology could become a powerful screening tool, especially for hard-to-detect cancers. Early detection remains one of the most effective ways to reduce cancer-related deaths, and this test could someday be used alongside traditional screenings like mammograms, colonoscopies, or CT scans.

Though not yet widely available, the multicancer test marks a hopeful step toward more proactive and personalized cancer care—potentially giving patients more options, earlier interventions, and better outcomes.